Area of research
Cancer Research · Immunology
Research interest
Research interests include MicroRNA in disease regulation, Atherosclerosis and Cardiovascular Diseases, Hepatitis C virus research, and Circular RNAs in diseases.
<i>Mir147</i> Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis.
miR-223-3p Prevents Necroptotic Macrophage Death by Targeting Ripk3 in a Negative Feedback Loop and Consequently Ameliorates Advanced Atherosclerosis.
Endothelial Overexpression of TGF-β-Induced Protein Impairs Venous Thrombus Resolution
Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice.
The Year of miR-223: How Platelets Can Kill Cardiomyocytes.
Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice.
MicroRNA-21 Controls Circadian Regulation of Apoptosis in Atherosclerotic Lesions.
Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium
Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium.
miR-103 promotes endothelial maladaptation by targeting lncWDR59
MicroRNA signatures in cardiac biopsies and detection of allograft rejection
MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease
Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3
Resolved and open issues in chromaffin cell development
Ablation of serum response factor in dopaminergic neurons exacerbates susceptibility towards MPTP‐induced oxidative stress